Episode 5: Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc

Episode 5 July 07, 2021 00:51:14
Episode 5:  Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 5: Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc

Jul 07 2021 | 00:51:14

/

Show Notes

On today’s podcast, host Wayne Bowden, Vice President of Partnerships and Strategy at Biorasi, talks with Will Maier, VP of Rare Disease, Drug Development Sciences at ICON plc, about clinical trial engagement in the rare disease patient community.

Other Episodes

Episode 34

October 10, 2023 00:44:45
Episode Cover

Episode 34: Dan Mandell, CEO at GRO Biosciences

"So we built the seatbelts before the car, so to speak, wherein we did a project to figure out ways to biocontain these organisms....

Listen

Episode 46

January 15, 2025 00:43:29
Episode Cover

Episode 46: Ben Olds and Amy Fenollosa, Haven Human Asset Ventures

"There's that old saying, 'culture is how people behave when nobody's looking.' So, if you want to be effective, your [mission and value statements]...

Listen

Episode 48

February 18, 2025 00:38:46
Episode Cover

Episode 48: John Celebi, President and CEO, Sensei Bio

"You have to have the right people, the right team, and good science." - John Celebi, President and CEO, Sensei Bio Welcome back to...

Listen